I guess I am interested to know what BEL have been up to for the past year? Dr Cornell has been visiting the US to coordinate on-going R&D without much info being released. Perhaps something will be announced about this soon a progress report anyway.
I don't imagine any takeover is likely, more funds will be needed to get setup for entry to US market and this is an opportunity for others to come in, also with all rights to markets outside of human medical field allocated to BEL the thing seems sown up.
I'm guessing US visit is just related to start of new financial year and related projects/funding negotiations.
ABI Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
